Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Inventory (2016 - 2025)

Utah Medical Products has reported Inventory over the past 16 years, most recently at $7.9 million for Q4 2025.

  • Quarterly results put Inventory at $7.9 million for Q4 2025, down 9.95% from a year ago — trailing twelve months through Dec 2025 was $7.9 million (down 9.95% YoY), and the annual figure for FY2025 was $7.9 million, down 9.95%.
  • Inventory for Q4 2025 was $7.9 million at Utah Medical Products, down from $8.1 million in the prior quarter.
  • Over the last five years, Inventory for UTMD hit a ceiling of $10.1 million in Q2 2023 and a floor of $6.0 million in Q1 2021.
  • Median Inventory over the past 5 years was $8.5 million (2022), compared with a mean of $8.3 million.
  • Biggest five-year swings in Inventory: fell 11.57% in 2021 and later soared 37.87% in 2023.
  • Utah Medical Products' Inventory stood at $6.6 million in 2021, then skyrocketed by 33.63% to $8.8 million in 2022, then increased by 8.71% to $9.6 million in 2023, then fell by 8.04% to $8.8 million in 2024, then dropped by 9.95% to $7.9 million in 2025.
  • The last three reported values for Inventory were $7.9 million (Q4 2025), $8.1 million (Q3 2025), and $8.2 million (Q2 2025) per Business Quant data.